Corporate Tech Investors

bioMerieux

bioMerieux is a corporate entity that invests in startup ventures that can advance its organizational interests.

Venture Investor Overview

Contact Information

Background Information

Overview

Our strategy is focused on pathologies and meeting the needs of clinicians, patients and consumers. We concentrate on infectious diseases - in particular, sepsis, hospital-acquired infections, tuberculosis, AIDS, and hepatitis - as well as on tests delivering high medical value for cancers (breast, colon, prostate) and emergency cardiovascular diseases.

Profile

Social Media

Company News

Facebook

YouTube

Last Transaction

5/6/2013

Transaction History

Our records indicate that bioMerieux invested in the VC transactions listed below. Dollar amounts are for the entire raise, which may include other investors.

Investor Contacts

Title

Name

Email & Social

Chief Executive Officer

Alexandre Merieux

        

Funds

No fund closings have been recorded for this company.

Portfolio Companies

bioMerieux has invested in the companies below, according to our database records. If we are missing a portfolio company, please let us know.

Browse more corporate investors:

BioMed Ventures | BioMotiv

Share this article

About Our Corporate Tech Investor Database

This corporate tech investor profile is powered by VentureDeal.com, a leading provider of corporate tech investing transaction data.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary